Yahoo Finance Press Release Source: S.A.N.E. Vax, Inc. On Monday November 8, 2010, 8:00 am EST TROY, Mont.–(BUSINESS WIRE)– In a letter addressed to Dr. Harold E. Varmus, director of the NCI, and Dr. Margaret Hamburg, FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc., requested that these two federal agencies recommend a reliable […]
NHS screening change ‘would cut smears’
BBC News 9 November 2010 By Michelle Roberts Health reporter, BBC News Women would need far fewer smears if the NHS switched to a new way of screening for cervical cancer, a Cancer Research UK scientist has said. Good uptake of the HPV vaccine that can prevent the cancer means we can now start to […]
Gardasil in the Developing World
University of Queensland
Researchers at the University of Queensland Diamantina Institute have confirmed through a study in Vanuatu that a test for human papilloma virus (HPV) could help control cervical cancer in developing countries.
Early detection has proven essential in controlling cervical cancer risk in developed countries where screening programs have reduced the prevalence of the disease by about 75%. Yet cervical cancer remains the second most common cancer in women and causes approximately 275,000 deaths worldwide each year. Due to severely limited access to adequate screening, the brunt of this mortality will be borne by women in developing countries where more than 80% of new cases occur each year.
GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate
Business Wire The Wall Street Journal CARLSBAD, Calif., Nov 02, 2010 (BUSINESS WIRE) — GenMark Diagnostics, Inc. /quotes/comstock/15*!gnmk/quotes/nls/gnmk (GNMK 4.34, -0.16, -3.56%) , a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics’ Hepatitis C Virus (HCV) genotyping patent estate for the United States. The […]
U.S. Says Genes Should Not Be Eligible for Patents
New York Times By ANDREW POLLACK Published: October 29, 2010 Reversing a longstanding policy, the federal government said on Friday that human and other genes should not be eligible for patents because they are part of nature. The new position could have a huge impact on medicine and on the biotechnology industry. The new position […]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- Next Page »
